Influence of late gadolinium enhancement on left ventricular morphology and function in patients with sarcoidosis

Influence of late gadolinium enhancement on left ventricular morphology and function in patients with sarcoidosis

Bibliographic Details
Main Authors:	Archer Stephen L, Hogarth Douglas K, Niewold Timothy B, Burke Martin C, DeCara Jeanne M, Spencer Kirk T, Sugeng Lissa, Chandra Sonal, Sweiss Nadera J, Patel Amit R, Beshai John F
Format:	Article
Language:	English
Published:	Elsevier 2009-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
by: Christian Ascoli, et al.
Published: (2022-10-01)

Late gadolinium enhancement and T2 MR imaging features of cardiac sarcoidosis involving the left and right ventricle
by: Kim Danny, et al.
Published: (2009-01-01)

Arrhythmogenic Left Ventricular Mass as the Initial Presentation of Cardiac Sarcoidosis
by: Erika Hutt, MD, et al.
Published: (2024-03-01)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
by: Macron Laurent, et al.
Published: (2013-01-01)

Late Gadolinium Enhancement of the right ventricular myocardium: Is it really different from the left ?
by: Macgowan Christopher K, et al.
Published: (2008-05-01)

Cardiac sarcoidosis with multiple left ventricular aneurysms (LVAs) in a young male
by: Dibya Kumar Baruah, et al.
Published: (2023-04-01)

Prognostic Value of Late Gadolinium Enhancement in Left Ventricular Noncompaction: A Multicenter Study
by: Wei Huang, et al.
Published: (2022-10-01)

Can left ventricular entropy by cardiac magnetic resonance late gadolinium enhancement be a prognostic predictor in patients with left ventricular non-compaction?
by: Yun-Ting Ma, et al.
Published: (2023-09-01)

Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis
by: Yuka Akama, et al.
Published: (2024-03-01)

Right ventricle late gadolinium enhancement in cardiac sarcoidosis: a case series
by: Merchant Naeem, et al.
Published: (2011-02-01)

Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance
by: Sorin Giusca, et al.
Published: (2021-07-01)

Co-occurrence of Myocardial Sarcoidosis and Left Ventricular Non-compaction in a Patient with Advanced Heart Failure
by: Anupam A Kumar, et al.
Published: (2022-06-01)

Quantitative assessment of late gadolinium-enhancement in cardiac magnetic resonance predicts left ventricular remodeling in acute myocarditis
by: Villoteau Serge, et al.
Published: (2010-01-01)

Patterns of Left Ventricular Hypertrophy and Late Gadolinium Enhancement onCardiac Magnetic Resonanace in Patients with Hypertrophic Cardiomyopathy
by: Sobia Mehreen, et al.
Published: (2022-11-01)

Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
by: Shuji Sakai, et al.
Published: (2011-02-01)

The use of volumetric analysis to improve cardiac magnetic resonance evaluation of left ventricular size and function
by: Schummers Georg, et al.
Published: (2009-01-01)

Evaluation and Catheter Ablation of Ventricular Arrhythmias in Cardiac Sarcoidosis
by: Fatima M. Ezzeddine, et al.
Published: (2022-11-01)

Malignant ventricular arrhythmia as the first manifestation of cardiac sarcoidosis
by: Ahmet Taha Alper, et al.
Published: (2013-09-01)

Heart Failure, Atrioventricular Block, and Ventricular Tachycardia in Sarcoidosis
by: David G. Rosenthal, et al.
Published: (2021-03-01)

Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy
by: Chen Zhang, et al.
Published: (2022-08-01)

Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its role
by: Hironori Yamamoto, et al.
Published: (2023-11-01)

Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review
by: Jaleel Jerry G. Sweis, et al.
Published: (2022-01-01)

Segmentation of left ventricle in late gadolinium enhanced MRI through 2D‐4D registration for infarct localization in 3D patient‐specific left ventricular model
by: Leong, Chen Onn, et al.
Published: (2019)

Assessment of left atrial fibrosis progression in canines following rapid ventricular pacing using 3D late gadolinium enhanced CMR images.
by: Nadia A Farrag, et al.
Published: (2022-01-01)

Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance.
by: Pegg, T, et al.
Published: (2010)

Editorial: Pulmonary sarcoidosis
by: Sahajal Dhooria, et al.
Published: (2023-03-01)

117 Late gadolinium enhancement of the right ventricle – is it really different from the left?
by: Vidarsson Logi, et al.
Published: (2008-10-01)

Giant left ventricular thrombus extending into the left ventricular outflow tract
by: Kudret Keskin, et al.
Published: (2015-12-01)

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma
by: Natarajan Arun, et al.
Published: (2013-01-01)

Different Phenotypes of Sarcomeric <i>MyBPC3</i>-Cardiomyopathy in the Same Family: Hypertrophic, Left Ventricular Noncompaction and Restrictive Phenotypes (in Association with Sarcoidosis)
by: Olga Blagova, et al.
Published: (2022-07-01)

Ventricular Tachycardia Storm in Cardiac Sarcoidosis: A 76-Day-ICU-Nightmare
by: Dr. Ajay M. Naik, MD, DM, DNB, FACC, FHRS, et al.
Published: (2012-11-01)

Short‐time ventricular tachycardia ablation for cardiac sarcoidosis using coherent map
by: Takashi Hiruma, et al.
Published: (2022-06-01)

Sarcoidosis or metastatic rectal cancer? Diligent diagnosis for optimal therapeutic management
by: Tanya Odisho, et al.
Published: (2022-12-01)

Left Ventricular Pseudoaneurysm
by: Isabel Cruz, MD, et al.
Published: (2024-03-01)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes
by: Lesley Ann Saketkoo, et al.
Published: (2021-06-01)

Effects of Allopurinol on the Left ventricular Ejection Fraction in Patients with Left Ventricular Failure
by: Mahmoud Hadizadeh, et al.
Published: (2007-12-01)

Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
by: Avi Aronov, et al.
Published: (2022-12-01)

Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis
by: Christen L. Vagts, et al.
Published: (2023-01-01)

Gadolinium enhanced magnetic resonance mean voxel signal intensity within the left ventricular myocardium changes prior to ejection fraction drop after receipt of cardiotoxic chemotherapy
by: Robbins Mike, et al.
Published: (2009-01-01)

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
by: Michael Quail, et al.
Published: (2019-01-01)